A Step-wise Approach for Transfer of Immunogenicity Assays during Clinical Drug Development

Journal Title: The AAPS Journal - Year 2009, Vol 11, Issue 3

Abstract

We designed a three-step statistical approach to transfer bioanalytical assays (ELISA and Biacore) which evaluates the (1) average equivalence between the two labs (2) concordance in individual sample results between the two labs, and (3) long-term stability of assay performance. Each experimental design evaluated the contribution of four critical variables to the overall variability. Two lots of each variable were examined in a controlled experiment. The variables tested for ELISA were analyst, plate washer, biotinylated-therapeutic protein, and streptavidin–horseradish peroxidase; and for Biacore were analyst, instrument, chip lot, and conjugation chemistry reagent lots. Equivalence in the mean signal to noise (S/N) or mean relative units (RU) between the two labs was established through statistical evaluation of the assay performance characteristics across multiple assay variables. Concordance between the two labs in the individual sample results was subsequently verified both quantitatively and qualitatively. The long-term maintenance of assay stability was monitored by performance testing of a predefined set of samples which were prepared in sufficient quantities to last several years. The process of method validation for biomarker testing in clinical trials is to analyze the variability of the assay performance. However, different factors contribute to this variability and need to be evaluated when the method is transferred to another site/lab. Lack of understanding the critical variables can potentially result in unexpected problems and delays. The three-step statistical approach of assay transfer provides a robust process for transferring complex biological assays.

Authors and Affiliations

Suzanna Tatarewicz, Michael Moxness, Dohan Weeraratne, Lei Zhou, Michael Hale, Steven J. Swanson, Narendra Chirmule

Keywords

Related Articles

Maturation and growth of renal function: Dosing renally cleared drugs in children

A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (QR). Published RFP values...

Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process

One useful concept that is aligned with the idea of an automated data interchange process is the Globally Unique ID (GUID), also known as a Universally Unique Identifier. These special purpose identifiers are 32-characte...

2-Arachidonoylglycerol (2-AG) membrane transport: History and outlook

Only a few studies have addressed the transport of 2-arachidonoylglycerol (2-AG), a naturally occurring agonist for cannabinoid receptors. Based upon saturation kinetics, these early reports have proposed that 2-AG enter...

Introduction: A welcome to the first special animal health issue of AAPS PharmSci

The goal of this special volume is to provide veterinary scientists with state-of-the art reviews in animal health and to inform human health scientists of the various challenges and collaborative opportunities associate...

High Sensitivity RT-qPCR Assay of Nonlabeled siRNA in Small Blood Volume for Pharmacokinetic Studies: Application to Survivin siRNA

The online version of this article (doi:10.1208/s12248-015-9812-y) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681487
  • DOI  10.1208/s12248-009-9130-3
  • Views 100
  • Downloads 0

How To Cite

Suzanna Tatarewicz, Michael Moxness, Dohan Weeraratne, Lei Zhou, Michael Hale, Steven J. Swanson, Narendra Chirmule (2009). A Step-wise Approach for Transfer of Immunogenicity Assays during Clinical Drug Development. The AAPS Journal, 11(3), -. https://www.europub.co.uk/articles/-A-681487